EP 0866851 A1 19980930 - TUMOUR VACCINE AND PROCESS FOR THE PREPARATION THEREOF
Title (en)
TUMOUR VACCINE AND PROCESS FOR THE PREPARATION THEREOF
Title (de)
TUMORVAKZINE UND VERFAHREN ZU IHRER HERSTELLUNG
Title (fr)
VACCIN TUMORAL ET SON PROCEDE DE FABRICATION
Publication
Application
Priority
- DE 19543649 A 19951123
- DE 19607044 A 19960224
- EP 9605126 W 19961121
Abstract (en)
[origin: WO9719169A1] The invention relates to a tumour vaccine and a process for the preparation thereof. The tumour vaccine contains tumour cells, at least a portion of which has at least one MHC-I-haplotype of the patient on the cell surface, and which have been loaded in such a manner with one or a plurality of peptides bonding to the MHC-I-molecule that said tumour cells are recognised as foreign within the context of the peptides by the patient's immune system and trigger a cellular immune response. Loading takes place in the presence of a polycation such as polylysine.
IPC 1-7
C12N 5/08; A61K 35/14; A61K 35/26; A61K 39/12; A61K 38/19; C07K 14/725
IPC 8 full level
A61K 31/00 (2006.01); A61K 35/12 (2006.01); A61K 38/00 (2006.01); A61K 38/19 (2006.01); A61K 38/21 (2006.01); A61K 39/00 (2006.01); C12N 5/10 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01); C12N 5/071 (2010.01); C12N 5/09 (2010.01)
CPC (source: EP KR US)
A61K 35/14 (2013.01 - KR); A61K 39/0011 (2013.01 - EP KR US); A61K 39/12 (2013.01 - EP US); A61K 39/145 (2013.01 - EP US); A61K 39/39 (2013.01 - EP US); A61P 35/00 (2018.01 - EP); C07K 7/06 (2013.01 - EP US); C07K 14/7051 (2013.01 - KR); C12N 5/0693 (2013.01 - KR); A61K 39/00 (2013.01 - EP KR US); A61K 2039/5154 (2013.01 - EP KR US); A61K 2039/55511 (2013.01 - EP US); A61K 2039/55516 (2013.01 - EP US); A61K 2039/55522 (2013.01 - EP US); A61K 2039/55561 (2013.01 - EP US); A61K 2039/585 (2013.01 - EP US)
C-Set (source: EP KR US)
EP US
KR
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9719169 A1 19970529; AR 004341 A1 19981104; AU 720131 B2 20000525; AU 7694796 A 19970611; BG 102439 A 19990129; BG 62999 B1 20010131; BR 9611466 A 19990518; CA 2238176 A1 19970529; CN 1202931 A 19981223; CO 4520254 A1 19971015; CZ 158998 A3 19990616; EE 03778 B1 20020617; EE 9800161 A 19981215; EP 0866851 A1 19980930; HU P0000318 A2 20000628; HU P0000318 A3 20020228; JP 2000502052 A 20000222; KR 19990067653 A 19990825; NO 982329 D0 19980522; NZ 322910 A 20000526; PL 188537 B1 20050228; PL 326756 A1 19981026; RO 115275 B1 19991230; RU 2206329 C2 20030620; SK 66998 A3 19981202; TR 199800912 T2 19980821; TW 514530 B 20021221; US 2002085997 A1 20020704; UY 24367 A1 20001031; UY 24430 A1 19970701
DOCDB simple family (application)
EP 9605126 W 19961121; AR P960105291 A 19961122; AU 7694796 A 19961121; BG 10243998 A 19980508; BR 9611466 A 19961121; CA 2238176 A 19961121; CN 96198493 A 19961121; CO 96061701 A 19961122; CZ 158998 A 19961121; EE 9800161 A 19961121; EP 96939870 A 19961121; HU P0000318 A 19961121; JP 51939597 A 19961121; KR 19980703681 A 19980515; NO 982329 A 19980522; NZ 32291096 A 19961121; PL 32675696 A 19961121; RO 9800985 A 19961121; RU 98111622 A 19961121; SK 66998 A 19961121; TR 9800912 T 19961121; TW 85114455 A 19961123; US 7721498 A 19980526; UY 24367 A 19961119; UY 24430 A 19970103